Skip to main content
OpenTrials
Completed

NCT Number: NCT02526927

Bone Microarchitecture Evaluation by HR-pQCT in Youngs Who Developed AN in Peri or Prepubertal Period.

The occurrence of anorexia nervosa (AN) during childhood or adolescence rapidly induces starvation, stop of growth and impaired mineralization of bone tissue together with an interruption of pubertal development. These consequences are initially reversible following food intake return but can lead to a more irreversible status with low height, osteoporosis and high fracture risk. The onset of the disease more and more early in life, with the first stages of puberty suggest that these consequences will be even more severe as bone resistance will be damaged by more profound effects on bone growth as well. It is therefore critical to evaluate these bone metabolism alterations in order to better manage these patients.

At every age and in every clinical circumstance either physiologic or pathologic, high resolution peripheral quantitative computerized tomography (HRpQCT) provides an evaluation of bone microarchitecture that is more informative than the global quantitative assessment given by conventional Dual Energy X-ray Absorptiometry) DEXA, with a better estimate of clinical fracture risk.

Here, we propose to measure cortical parameters, such as cortical thickness which plays a key role in bone biomechanical strength in young adults aged between 20 and 30 years-old, who had developed AN as early as the during the first stages of puberty but no longer present, compared to age-and sex-matched healthy volunteers. Other micro-architectural parameters will also be studied. In an exploratory phase, we will evaluate these bone microarchitectural parameters together with bone biological turnover markers and markers of sexual maturation in adolescents or young adults 20 years-old or less, undernourished and currently managed for AN.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anorexia Nervosa Feeding and Eating Disorders Mental Disorders

Age range

10 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU de SAINT-ETIENNE

Saint-Etienne, 42000, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients over 20 years old:
  • Age > 20 and < 30 years old
  • Patients managed for AN in the pediatric or endocrinology of the university hospital of St-Etienne
  • Patients who developed AN as early as the during the first stages of puberty defined by Tanner stage 1 to 4, with a diagnosis of AN based on DSM-IV current criteria:
  • Weight loss : deny of maintaining body weight over minimal normal threshold (85 % age and height matched)
  • Intense fear of gaining weight or becoming obese despite weight insufficiency;
  • Impaired perception of weight or dysmorphophobia;
  • Excessive role of weight or body shape in self-esteem or deny of current leanness;
  • Secondary amenorrhea during 3 or more menstrual cycles in young girls or primary amenorrhea
  • Duration of AN of at least 6 months
  • BMI >85% of theoretical BMI (efficient renutrition)
  • Patients less than 20 years old :
  • Age > 10 and < 20 years old
  • Patients managed for AN in the pediatric or endocrinology of the university hospital of St-Etienne
  • Patients who developed AN as early as the during the first stages of puberty defined by Tanner stage 1 to 4, with a diagnosis of AN based on DSM-IV current criteria:
  • Weight loss : deny of maintaining body weight over minimal normal threshold (85 % age and height matched)
  • Intense fear of gaining weight or becoming obese despite weight insufficiency;
  • Impaired perception of weight or dysmorphophobia;
  • Excessive role of weight or body shape in self-esteem or deny of current leanness;
  • Secondary amenorrhea during 3 or more menstrual cycles in young girls or primary amenorrhea
  • Duration of AN of at least 6 months

Exclusion criteria

  • Renal insufficiency
  • Cushing
  • Dysthyroidism
  • Inflammatory disease
  • Pregnancy
  • Lack of consent
  • Subject under legal protection

Treatment and study plan

HR-pQCT

Device

The Xtrem CT scanco device is a HR-pQCT used for 3D bone measurements at the tibia and the radius levels in human

Other names: Xtrem CT scanco

DEXA

Device

The Lunar DEXA (Dual Energy X-ray Absorptiometry) is a third generation multi-captor DEXA device that allows short duration measurements (< 15 min). It measures Bone Mineral Density at the spine (L1-L4) and the femoral neck

Blood Samples

Other

Primary outcomes

  1. Cortical thickness

    Time frame: Day 1

    Cortical thickness (in mm) is a composite outcome measured with HR pQCTon 3D images of distal radius and distal tibia.

Secondary outcomes

  1. Number of patients with bone degradation

    Time frame: Day 1

    Bone degradation is a composite outcome measured by cortical and architectural parameters measured with HR pQCTon 3D images of distal radius and distal tibia. The parameters are : Total volumetric bone mineral density (mg/ccm HA), Trabecular volumetric bone mineral density (mg/ccm HA), Cortical volumetric bone mineral density (mg/ccm HA), Number of bone trabeculae (1/mm), Trabecular thickness (mm) Cortical thickness (mm), Trabecular spacing (mm), Trabecular distribution (mm)

  2. number of patients with osteoporosis

    Time frame: Day 1

    Osteoporosis is measured with DEXA. DEXA measure the Bone Mineral Density (g/cm2)

  3. Clinical and biological phenotype of AN patients 20 years-old or less

    Time frame: Day 1

    Clinical and biological phenotype of AN patients 20 years-old or less is a composite factor : Pubertal stage at disease onset, Duration of AN, Height shortening compared to optimal genetically defined height, Serum levels of FGF23, Serum levels of IGF 1, Serum levels of sexual steroids (FSH, LH, oestradiol, testosterone, SeBG, AMH, inhibin B), Serum levels of bone formation and resorption markers (cross laps, osteocalcin, total alkaline phosphatases), Serum levels of leptin, Bone mineral density measured by DXA

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Saint Etienne

Other

Registry information

Official study title

Monocentric Study Evaluating Bone Microarchitecture by High Resolution Quantitative Computerized Tomography (HR-pQCT) in Young Adults and Adolescents Who Developed Anorexia Nervosa (AN) in Peri or Prepubertal Period.

Acronym: AMOS

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Aug 18, 2015
Registry last updated
Feb 22, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.